Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2217/nnm-2021-0024 http://scihub22266oqcxt.onion/10.2217/nnm-2021-0024 33988035!8120867!33988035     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Nanomedicine+(Lond) 2021 ; 16 (14): 1203-1218 Nephropedia Template TP {{tp|p=33988035|t=2021. Nanomedicine for the poor: a lost cause or an idea whose time has yet to come?|pdf=|usr=}}{{33988035}} gab.com Text Nanomedicine for the poor: a lost cause or an idea whose time has yet to come JO: Nanomedicine (Lond) http://www.kidney.de/pget.php?&tw=1&pmid=33988035 #FOAvip The most effective COVID-19 vaccines, to date, utilize nanotechnology to deliver immunostimulatory mRNA. However, their high cost equates to low affordability. Total nano-vaccine purchases per capita and their proportion within the total vaccine lots have increased directly with the GDP per capita of countries. While three out of four COVID-19 vaccines procured by wealthy countries by the end of 2020 were nano-vaccines, this amounted to only one in ten for middle-income countries and nil for the low-income countries. Meanwhile, economic gains of saving lives with nano-vaccines in USA translate to large costs in middle-/low-income countries. It is discussed how nanomedicine can contribute to shrinking this gap between rich and poor instead of becoming an exquisite technology for the privileged. Two basic routes are outlined: (1) the use of qualitative contextual analyses to endorse R&D that positively affects the sociocultural climate; (2) challenging the commercial, competitive realities wherein scientific innovation of the day operates. Twit Text FOAVip Nanomedicine for the poor: a lost cause or an idea whose time has yet to come ????Nanomedicine (Lond) http://www.kidney.de/pget.php?&tw=1&pmid=33988035 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33988035 #FOAvip English Wikipedia <ref>{{Cite pmid|33988035}}</ref> Nanomedicine for the poor: a lost cause or an idea whose time has yet to come? #MMPMID33988035 Uskokovic V Nanomedicine (Lond) 2021[Jun]; 16 (14): 1203-1218 PMID33988035show ga The most effective COVID-19 vaccines, to date, utilize nanotechnology to deliver immunostimulatory mRNA. However, their high cost equates to low affordability. Total nano-vaccine purchases per capita and their proportion within the total vaccine lots have increased directly with the GDP per capita of countries. While three out of four COVID-19 vaccines procured by wealthy countries by the end of 2020 were nano-vaccines, this amounted to only one in ten for middle-income countries and nil for the low-income countries. Meanwhile, economic gains of saving lives with nano-vaccines in USA translate to large costs in middle-/low-income countries. It is discussed how nanomedicine can contribute to shrinking this gap between rich and poor instead of becoming an exquisite technology for the privileged. Two basic routes are outlined: (1) the use of qualitative contextual analyses to endorse R&D that positively affects the sociocultural climate; (2) challenging the commercial, competitive realities wherein scientific innovation of the day operates. |*COVID-19[MESH] |*COVID-19 Vaccines[MESH] |*Nanomedicine[MESH] |*Poverty[MESH]Nanomedicine for the poor: a lost cause or an idea whose time has yet (epmc).pdf DeepDyve Pubget Overpricing